Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
2,387.03
2,528.58
2,716.05
2,488.65
2,154.78
1,806.09
1,560.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,387.03
2,528.58
2,716.05
2,488.65
2,154.78
1,806.09
1,560.94
Raw Material Cost
1,433.84
1,571.98
1,768.97
1,666.36
1,221.52
1,141.92
998.90
Purchase of Finished goods
84.34
80.23
121.29
108.57
111.24
88.32
44.25
(Increase) / Decrease In Stocks
19.46
25.51
-1.75
-86.08
-11.72
-51.28
16.82
Employee Cost
112.10
102.34
92.02
82.64
80.50
69.36
60.92
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
450.23
432.06
429.92
387.72
316.13
295.95
232.69
Total Expenditure (Excl Depreciation)
2,099.97
2,212.12
2,410.45
2,159.21
1,717.67
1,544.27
1,353.58
Operating Profit (PBDIT) excl Other Income
287.06
316.46
305.60
329.44
437.11
261.82
207.36
Other Income
16.36
4.03
2.19
11.32
4.53
1.48
2.41
Operating Profit (PBDIT)
303.42
320.49
307.79
340.76
441.64
263.30
209.77
Interest
35.87
33.52
33.29
20.75
22.96
33.73
39.96
Exceptional Items
0.00
0.00
0.00
0.00
0.21
4.47
3.77
Gross Profit (PBDT)
267.55
286.97
274.50
320.01
418.89
234.04
173.58
Depreciation
55.78
51.45
50.32
50.05
49.88
48.75
42.56
Profit Before Tax
211.77
235.52
224.18
269.96
369.01
185.29
131.02
Tax
43.67
63.93
57.82
64.96
88.61
43.89
41.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
168.10
171.59
166.36
205.00
280.40
141.40
89.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
168.10
171.59
166.36
205.00
280.40
141.40
89.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.06
-0.17
-0.05
0.04
0.01
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
168.16
171.42
166.31
205.04
280.41
141.40
89.75
Equity Capital
91.27
91.94
92.60
92.60
93.20
23.30
23.58
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,277.73
1,189.61
1,099.83
943.76
820.22
629.19
519.86
Earnings per share (EPS)
18.42
18.64
17.96
22.14
30.09
15.17
9.52
Diluted Earnings per share
18.35
18.56
17.97
22.12
30.09
60.57
38.48
Operating Profit Margin (Excl OI)
12.03%
12.52%
11.25%
13.24%
20.29%
14.5%
13.28%
Gross Profit Margin
11.21%
11.35%
10.11%
12.86%
19.44%
12.96%
11.12%
PAT Margin
7.04%
6.79%
6.13%
8.24%
13.01%
7.83%
5.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -5.60% vs -6.90% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -1.90% vs 3.07% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -9.29% vs 3.55% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 7.01% vs 0.69% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Aarti Drugs With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
2,387.03
1,243.68
1,143.35
91.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,387.03
1,243.68
1,143.35
91.93%
Raw Material Cost
1,433.84
799.82
634.02
79.27%
Purchase of Finished goods
84.34
39.22
45.12
115.04%
(Increase) / Decrease In Stocks
19.46
-24.94
44.40
178.03%
Employee Cost
112.10
116.78
-4.68
-4.01%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
450.23
126.64
323.59
255.52%
Total Expenditure (Excl Depreciation)
2,099.97
1,057.52
1,042.45
98.57%
Operating Profit (PBDIT) excl Other Income
287.06
186.16
100.90
54.20%
Other Income
16.36
12.05
4.31
35.77%
Operating Profit (PBDIT)
303.42
198.21
105.21
53.08%
Interest
35.87
2.41
33.46
1,388.38%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
267.55
195.80
71.75
36.64%
Depreciation
55.78
24.78
31.00
125.10%
Profit Before Tax
211.77
171.02
40.75
23.83%
Tax
43.67
42.76
0.91
2.13%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
168.10
128.26
39.84
31.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
168.10
128.26
39.84
31.06%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.06
0.00
0.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
168.16
128.26
39.90
31.11%
Equity Capital
91.27
57.23
34.04
59.48%
Face Value
10.00
10.00
0.00
Reserves
1,277.73
902.19
375.54
41.63%
Earnings per share (EPS)
18.42
22.41
-3.99
-17.80%
Diluted Earnings per share
18.35
22.41
-4.06
-18.12%
Operating Profit Margin (Excl OI)
12.03%
14.97%
0.00
-2.94%
Gross Profit Margin
11.21%
15.74%
0.00
-4.53%
PAT Margin
7.04%
10.31%
0.00
-3.27%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,387.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.60% vs -6.90% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 168.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.90% vs 3.07% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 287.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -9.29% vs 3.55% in Mar 2024
Annual - Interest
Interest 35.87 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 7.01% vs 0.69% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.03%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024






